HAMF
ECYT

Hatteras Alternative Mutual Funds’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Hatteras Alternative Mutual Funds’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,701
Closed -$169K – 203
2013
Q3 		$169K Sell
12,701
-4,459
-26% -$70.5K 0.11% 150
2013
Q2 		$225K Buy
+17,160
New +$231K 0.24% 124

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Hatteras Alternative Mutual Funds's ECYT Position: Q4 2013 in Review

Hatteras Alternative Mutual Funds sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2013, closing a stake of 12,701 shares — an estimated $169K sold.

Hatteras Alternative Mutual Funds first reported a position in ECYT in Q2 2013 and held it in 2 quarters. The position peaked at $225K in Q2 2013. 90 funds tracked by Wall St. Rank hold ECYT as of Q4 2013.

  • Hatteras Alternative Mutual Funds reported no remaining Endocyte, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Hatteras Alternative Mutual Funds sold 12,701 Endocyte, Inc. Common Stock shares in Q4 2013, an estimated $169K.
  • Hatteras Alternative Mutual Funds first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 2 quarters.
  • Hatteras Alternative Mutual Funds's Endocyte, Inc. Common Stock position peaked at $225K in Q2 2013.
  • 90 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2013.

Based on Hatteras Alternative Mutual Funds's 13F filing for Q4 2013, filed 14 Feb 2014.